Peridural analgesia may affect long-term survival in patients with colorectal cancer after surgery (PACO-RAS-Study): An analysis of a cancer registry

Annals of Surgery

Volumn 258, Issue 6, 2013, Pages 989-993

  Holler, Julia P N ^a   Ahlbrandt, Janko ^b   Burkhardt, Ernst ^c   Gruss, Marco ^d   Röhrig, Rainer ^b   Knapheide, Julia ^a   Hecker, Andreas ^a   Padberg, Winfried ^a   Weigand, Markus A ^b  

^a Department of General Visceral Vascular and Pediatric Surgery   (Germany)

^b Department of Anesthesiology Intensive Care and Pain Medicine   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d Klinikum Hanau GmbH   (Germany)

Author keywords

carcinoma; peridural analgesia; regional anesthesia; surgery; treatment

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CARCINOMA; EPIDURAL ANESTHESIA; FEMALE; GENERAL ANESTHESIA; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; ANALGESIA, EPIDURAL; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84888129252     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182915f61     Document Type: Article

References (36)

1. Gottschalk A, Sharma S, Ford J, et al. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg. 2010;110:1636-1643.
2. DenisMG, Lipart C, Leborgne J, et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer. 1997;74:540-544.
3. Rosendahl W, Schulz U, Teufel T, et al. Surgical stress and neuroendocrine responses in infants and children. J Pediatr Endocrinol Metab. 1995;8:187-194.
4. Schlagenhauff B, Ellwanger U, Breuninger H, et al. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 2000;10:165-169.
5. Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology. 2007;106:499-506.
6. Bar-Yosef S, Melamed R, Page GG, et al. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology. 2001;94:1066-1073.
7. Melamed R, Rosenne E, Shakhar K, et al. Marginating pulmonary-NK activity and resistance to experimental tumormetastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun. 2005;19:114-126.
8. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun. 2003;17(suppl 1):S27-S36.
9. Sacerdote P, Manfredi B, Bianchi M, et al. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte betaendorphin concentrations in the rat. Brain Behav Immun. 1994;8:251-260.
10. Shavit Y, Martin FC, Yirmiya R, et al. Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav Immun. 1987;1:318-328.
11. Antoni MH, Lutgendorf SK, Cole SW, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006;6:240-248.
12. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res. 2008;659:15-30.
13. Lewis JW, Shavit Y, Terman GW, et al. Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides. 1983;4:635-638.
14. Yeager MP, Colacchio TA, Yu CT, et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 1995;83:500-508.
15. Sacerdote P, Bianchi M, Gaspani L, et al. The effects of tramadol andmorphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 2000;90:1411-1414.
16. Beilin B, Shavit Y, Hart J, et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg. 1996;82:492-497.
17. Ben-Eliyahu S, Page GG, Yirmiya R, et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80:880-888.
18. Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 2002;62:4491-4498.
19. Yeager MP, ProcopioMA, DeLeo JA, et al. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans. Anesth Analg. 2002;94:94-99, table of contents.
20. Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008;22:263-277.
21. O'Riain SC, Buggy DJ, Kerin MJ, et al. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg. 2005;100:244-249.
22. Biki B, Mascha E, Moriarty DC, et al. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology. 2008;109:180-187.
23. Lin L, Liu C, Tan H, et al. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth. 2011;106:814-822.
24. Christopherson R, James KE, Tableman M, et al. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg. 2008;107:325-332.
25. Myles PS, Peyton P, Silbert B, et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ. 2011;342:d1491.
26. Altmann U, Dudeck J. The Giessen Tumor Documentation System (GTDS)-review and perspectives. Methods Inf Med. 2006;45:108-115.
27. Greene FL, Page DL, Fleming ID, et al; for the American Joint Committee on Cancer, eds. Cancer Staging Manual. 6th ed. London, England: Springer; 2002.
28. de Gramont A, BuyseM, Abrahantes JC, et al. Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer. J Clin Oncol. 2007;25:3224-3229.
29. Rengan R, Paty P, Wong WD, et al. Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection? J Clin Oncol. 2005;23: 4905-4912.
30. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl JMed. 2001;345:638-646.
31. Francini G, Petrioli R, Lorenzini L, et al. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology. 1994;106:899-906.
32. Dube S, Heyen F, Jenicek M. Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis. Dis Colon Rectum. 1997;40:35-41.
33. Benson M, Junger A, Quinzio L, et al. Data processing at the anesthesia workstation: from data entry to data presentation. Methods Inf Med. 2000;39:319-324.
34. American Society of Anesthesiologists (ASA). ASA Physical Status Classification System. http://www.asahq.org/Home/For-Members/Clinical- Information/ASA-Physical-Status-Classification-System. Accessed April 18, 2013.
35. Liu SS, Block BM,Wu CL. Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery: a meta-analysis. Anesthesiology. 2004;101:153-161.
36. Tonnesen E, Wahlgreen C. Influence of extradural and general anaesthesia on natural killer cell activity and lymphocyte subpopulations in patients undergoing hysterectomy. Br J Anaesth. 1988;60:500-507.